Kaya Holdings (KAYS) Depreciation & Amortization (CF) (2011 - 2025)
Kaya Holdings (KAYS) recorded quarterly Depreciation & Amortization (CF) of $1943.0 in Q3 2025, little changed quarter-over-quarter from $1942.0 in Q2 2025, and down 11.4% on a YoY basis from $2193.0 in Q3 2024.
Kaya Holdings (KAYS) Depreciation & Amortization (CF) (2011 - 2025) Analysis & Trends
Kaya Holdings' Depreciation & Amortization (CF) history runs 15 years deep, the most recent figure standing at $1943.0 for Q3 2025.
- In Q3 2025, Depreciation & Amortization (CF) fell 11.4% year-over-year to $1943.0; the TTM figure through Sep 2025 stood at $8330.0 (up 416.11% YoY), while the FY2024 annual figure was $5882.0, down 50.34% from the prior year.
- Depreciation & Amortization (CF) was $1943.0 for Q3 2025 at Kaya Holdings, roughly flat from $1942.0 in the prior quarter.
- In the past five years, Depreciation & Amortization (CF) ranged from a high of $60241.0 in Q2 2021 to a low of -$1766.0 in Q4 2023.
- Historically, Depreciation & Amortization (CF) has averaged $9082.0 across 5 years, with a median of $3298.0 in 2023.
- The sharpest annual moves came in 2022 and 2023: Depreciation & Amortization (CF) surged 1598.23% in 2022, then sank 143.06% in 2023.
- A 5-year view of Depreciation & Amortization (CF) shows it stood at $28818.0 in 2021, then plunged by 85.77% to $4101.0 in 2022, then tumbled by 143.06% to -$1766.0 in 2023, then surged by 241.68% to $2502.0 in 2024, then decreased by 22.34% to $1943.0 in 2025.
- The last three Depreciation & Amortization (CF) figures came in at $1943.0 (Q3 2025), $1942.0 (Q2 2025), and $1943.0 (Q1 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.97 Bn | 36.23 Bn | 1.97 Bn | 239.00 Mn |
| 2 | Zoetis | 33.59 Bn | 31.65 Bn | 1.62 Bn | 119.00 Mn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 22.60 Mn |
| 4 | Neurocrine Biosciences | 16.10 Bn | 14.78 Bn | 800.70 Mn | 7.20 Mn |
| 5 | Aurora Cannabis | 15.56 Bn | 15.47 Bn | 21.72 Mn | - |
| 6 | Elanco Animal Health | 12.04 Bn | 11.61 Bn | 785.00 Mn | 172.00 Mn |
| 7 | Alkermes | 7.36 Bn | 6.84 Bn | -116.06 Mn | 19.43 Mn |
| 8 | Lantheus Holdings | 6.74 Bn | 6.24 Bn | 230.92 Mn | 22.68 Mn |
| 9 | Liquidia | 6.27 Bn | 6.04 Bn | 121.79 Mn | 497,000.00 |
| 10 | Kaya Holdings | - | - | 5,370.00 | 1,943.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 1,943.00 |
| Sep 30, 2025 | 1,943.00 |
| Jun 30, 2025 | 1,942.00 |
| Jun 30, 2025 | 1,942.00 |
| Mar 31, 2025 | 1,943.00 |
| Mar 31, 2025 | 1,943.00 |
| Dec 31, 2024 | 2,502.00 |
| Dec 31, 2024 | 2,502.00 |
| Sep 30, 2024 | 2,193.00 |
| Sep 30, 2024 | 2,193.00 |
| Jun 30, 2024 | 230.00 |
| Jun 30, 2024 | 230.00 |
| Mar 31, 2024 | 957.00 |
| Mar 31, 2024 | 957.00 |
| Dec 31, 2023 | -1,766.00 |
| Dec 31, 2023 | -1,766.00 |
| Sep 30, 2023 | 6,796.00 |
| Sep 30, 2023 | 6,796.00 |
| Jun 30, 2023 | 3,298.00 |
| Jun 30, 2023 | 3,298.00 |